O Taşkapan, Y Harmanyeri. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anti-Allergic Agents/administration & dosageAnti-Allergic Agents/adverse effectsAnti-Allergic Agents/therapeutic useAntipruritics/administration & dosageAntipruritics/adverse effectsAntipruritics/therapeutic useAutoimmune Diseases/drug therapyChildChronic DiseaseHistamine H1 Antagonists/administration & dosageHistamine H1 Antagonists/adverse effectsHistamine H1 Antagonists/therapeutic useHumansImmunosuppressive Agents/therapeutic useKetotifen/administration & dosageKetotifen/adverse effectsKetotifen/therapeutic useSleep Stages/drug effectsThyroiditis, Autoimmune/complicationsUrticaria/complicationsUrticaria/drug therapyUrticaria/immunology
Substances: See more » Anti-Allergic AgentsAntipruriticsHistamine H1 AntagonistsImmunosuppressive AgentsKetotifen
Year: 1998 PMID: 9487221 DOI: 10.1001/archderm.134.2.240
Source DB: PubMed Journal: Arch Dermatol ISSN: 0003-987X